Cargando…
Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer
BACKGROUND: Citizen science, scientific research conducted by non-specialists, has the potential to facilitate biomedical research using available large-scale data, however validating the results is challenging. The Cell Slider is a citizen science project that intends to share images from tumors wi...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534635/ https://www.ncbi.nlm.nih.gov/pubmed/26288840 http://dx.doi.org/10.1016/j.ebiom.2015.05.009 |
_version_ | 1782385486553153536 |
---|---|
author | Candido dos Reis, Francisco J. Lynn, Stuart Ali, H. Raza Eccles, Diana Hanby, Andrew Provenzano, Elena Caldas, Carlos Howat, William J. McDuffus, Leigh-Anne Liu, Bin Daley, Frances Coulson, Penny Vyas, Rupesh J. Harris, Leslie M. Owens, Joanna M. Carton, Amy F.M. McQuillan, Janette P. Paterson, Andy M. Hirji, Zohra Christie, Sarah K. Holmes, Amber R. Schmidt, Marjanka K. Garcia-Closas, Montserrat Easton, Douglas F. Bolla, Manjeet K. Wang, Qin Benitez, Javier Milne, Roger L. Mannermaa, Arto Couch, Fergus Devilee, Peter Tollenaar, Robert A.E.M. Seynaeve, Caroline Cox, Angela Cross, Simon S. Blows, Fiona M. Sanders, Joyce de Groot, Renate Figueroa, Jonine Sherman, Mark Hooning, Maartje Brenner, Hermann Holleczek, Bernd Stegmaier, Christa Lintott, Chris Pharoah, Paul D.P. |
author_facet | Candido dos Reis, Francisco J. Lynn, Stuart Ali, H. Raza Eccles, Diana Hanby, Andrew Provenzano, Elena Caldas, Carlos Howat, William J. McDuffus, Leigh-Anne Liu, Bin Daley, Frances Coulson, Penny Vyas, Rupesh J. Harris, Leslie M. Owens, Joanna M. Carton, Amy F.M. McQuillan, Janette P. Paterson, Andy M. Hirji, Zohra Christie, Sarah K. Holmes, Amber R. Schmidt, Marjanka K. Garcia-Closas, Montserrat Easton, Douglas F. Bolla, Manjeet K. Wang, Qin Benitez, Javier Milne, Roger L. Mannermaa, Arto Couch, Fergus Devilee, Peter Tollenaar, Robert A.E.M. Seynaeve, Caroline Cox, Angela Cross, Simon S. Blows, Fiona M. Sanders, Joyce de Groot, Renate Figueroa, Jonine Sherman, Mark Hooning, Maartje Brenner, Hermann Holleczek, Bernd Stegmaier, Christa Lintott, Chris Pharoah, Paul D.P. |
author_sort | Candido dos Reis, Francisco J. |
collection | PubMed |
description | BACKGROUND: Citizen science, scientific research conducted by non-specialists, has the potential to facilitate biomedical research using available large-scale data, however validating the results is challenging. The Cell Slider is a citizen science project that intends to share images from tumors with the general public, enabling them to score tumor markers independently through an internet-based interface. METHODS: From October 2012 to June 2014, 98,293 Citizen Scientists accessed the Cell Slider web page and scored 180,172 sub-images derived from images of 12,326 tissue microarray cores labeled for estrogen receptor (ER). We evaluated the accuracy of Citizen Scientist's ER classification, and the association between ER status and prognosis by comparing their test performance against trained pathologists. FINDINGS: The area under ROC curve was 0.95 (95% CI 0.94 to 0.96) for cancer cell identification and 0.97 (95% CI 0.96 to 0.97) for ER status. ER positive tumors scored by Citizen Scientists were associated with survival in a similar way to that scored by trained pathologists. Survival probability at 15 years were 0.78 (95% CI 0.76 to 0.80) for ER-positive and 0.72 (95% CI 0.68 to 0.77) for ER-negative tumors based on Citizen Scientists classification. Based on pathologist classification, survival probability was 0.79 (95% CI 0.77 to 0.81) for ER-positive and 0.71 (95% CI 0.67 to 0.74) for ER-negative tumors. The hazard ratio for death was 0.26 (95% CI 0.18 to 0.37) at diagnosis and became greater than one after 6.5 years of follow-up for ER scored by Citizen Scientists, and 0.24 (95% CI 0.18 to 0.33) at diagnosis increasing thereafter to one after 6.7 (95% CI 4.1 to 10.9) years of follow-up for ER scored by pathologists. INTERPRETATION: Crowdsourcing of the general public to classify cancer pathology data for research is viable, engages the public and provides accurate ER data. Crowdsourced classification of research data may offer a valid solution to problems of throughput requiring human input. |
format | Online Article Text |
id | pubmed-4534635 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-45346352015-08-18 Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer Candido dos Reis, Francisco J. Lynn, Stuart Ali, H. Raza Eccles, Diana Hanby, Andrew Provenzano, Elena Caldas, Carlos Howat, William J. McDuffus, Leigh-Anne Liu, Bin Daley, Frances Coulson, Penny Vyas, Rupesh J. Harris, Leslie M. Owens, Joanna M. Carton, Amy F.M. McQuillan, Janette P. Paterson, Andy M. Hirji, Zohra Christie, Sarah K. Holmes, Amber R. Schmidt, Marjanka K. Garcia-Closas, Montserrat Easton, Douglas F. Bolla, Manjeet K. Wang, Qin Benitez, Javier Milne, Roger L. Mannermaa, Arto Couch, Fergus Devilee, Peter Tollenaar, Robert A.E.M. Seynaeve, Caroline Cox, Angela Cross, Simon S. Blows, Fiona M. Sanders, Joyce de Groot, Renate Figueroa, Jonine Sherman, Mark Hooning, Maartje Brenner, Hermann Holleczek, Bernd Stegmaier, Christa Lintott, Chris Pharoah, Paul D.P. EBioMedicine Original Article BACKGROUND: Citizen science, scientific research conducted by non-specialists, has the potential to facilitate biomedical research using available large-scale data, however validating the results is challenging. The Cell Slider is a citizen science project that intends to share images from tumors with the general public, enabling them to score tumor markers independently through an internet-based interface. METHODS: From October 2012 to June 2014, 98,293 Citizen Scientists accessed the Cell Slider web page and scored 180,172 sub-images derived from images of 12,326 tissue microarray cores labeled for estrogen receptor (ER). We evaluated the accuracy of Citizen Scientist's ER classification, and the association between ER status and prognosis by comparing their test performance against trained pathologists. FINDINGS: The area under ROC curve was 0.95 (95% CI 0.94 to 0.96) for cancer cell identification and 0.97 (95% CI 0.96 to 0.97) for ER status. ER positive tumors scored by Citizen Scientists were associated with survival in a similar way to that scored by trained pathologists. Survival probability at 15 years were 0.78 (95% CI 0.76 to 0.80) for ER-positive and 0.72 (95% CI 0.68 to 0.77) for ER-negative tumors based on Citizen Scientists classification. Based on pathologist classification, survival probability was 0.79 (95% CI 0.77 to 0.81) for ER-positive and 0.71 (95% CI 0.67 to 0.74) for ER-negative tumors. The hazard ratio for death was 0.26 (95% CI 0.18 to 0.37) at diagnosis and became greater than one after 6.5 years of follow-up for ER scored by Citizen Scientists, and 0.24 (95% CI 0.18 to 0.33) at diagnosis increasing thereafter to one after 6.7 (95% CI 4.1 to 10.9) years of follow-up for ER scored by pathologists. INTERPRETATION: Crowdsourcing of the general public to classify cancer pathology data for research is viable, engages the public and provides accurate ER data. Crowdsourced classification of research data may offer a valid solution to problems of throughput requiring human input. Elsevier 2015-05-09 /pmc/articles/PMC4534635/ /pubmed/26288840 http://dx.doi.org/10.1016/j.ebiom.2015.05.009 Text en © 2015 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Article Candido dos Reis, Francisco J. Lynn, Stuart Ali, H. Raza Eccles, Diana Hanby, Andrew Provenzano, Elena Caldas, Carlos Howat, William J. McDuffus, Leigh-Anne Liu, Bin Daley, Frances Coulson, Penny Vyas, Rupesh J. Harris, Leslie M. Owens, Joanna M. Carton, Amy F.M. McQuillan, Janette P. Paterson, Andy M. Hirji, Zohra Christie, Sarah K. Holmes, Amber R. Schmidt, Marjanka K. Garcia-Closas, Montserrat Easton, Douglas F. Bolla, Manjeet K. Wang, Qin Benitez, Javier Milne, Roger L. Mannermaa, Arto Couch, Fergus Devilee, Peter Tollenaar, Robert A.E.M. Seynaeve, Caroline Cox, Angela Cross, Simon S. Blows, Fiona M. Sanders, Joyce de Groot, Renate Figueroa, Jonine Sherman, Mark Hooning, Maartje Brenner, Hermann Holleczek, Bernd Stegmaier, Christa Lintott, Chris Pharoah, Paul D.P. Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer |
title | Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer |
title_full | Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer |
title_fullStr | Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer |
title_full_unstemmed | Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer |
title_short | Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer |
title_sort | crowdsourcing the general public for large scale molecular pathology studies in cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534635/ https://www.ncbi.nlm.nih.gov/pubmed/26288840 http://dx.doi.org/10.1016/j.ebiom.2015.05.009 |
work_keys_str_mv | AT candidodosreisfranciscoj crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT lynnstuart crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT alihraza crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT ecclesdiana crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT hanbyandrew crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT provenzanoelena crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT caldascarlos crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT howatwilliamj crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT mcduffusleighanne crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT liubin crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT daleyfrances crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT coulsonpenny crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT vyasrupeshj crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT harrislesliem crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT owensjoannam crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT cartonamyfm crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT mcquillanjanettep crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT patersonandym crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT hirjizohra crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT christiesarahk crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT holmesamberr crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT schmidtmarjankak crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT garciaclosasmontserrat crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT eastondouglasf crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT bollamanjeetk crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT wangqin crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT benitezjavier crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT milnerogerl crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT mannermaaarto crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT couchfergus crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT devileepeter crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT tollenaarrobertaem crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT seynaevecaroline crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT coxangela crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT crosssimons crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT blowsfionam crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT sandersjoyce crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT degrootrenate crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT figueroajonine crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT shermanmark crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT hooningmaartje crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT brennerhermann crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT holleczekbernd crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT stegmaierchrista crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT lintottchris crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer AT pharoahpauldp crowdsourcingthegeneralpublicforlargescalemolecularpathologystudiesincancer |